gi-hepatology
Ho Index for Predicting Response to Medical Therapy in IBD
Clinical index predicting long-term steroid-free remission in patients with IBD treated with azathioprine or 6-mercaptopurine. Helps identify patients unlikely to respond to thiopurines who may benefit from early biologic therapy.
References
- Ho GT et al. The use of immunosuppressive therapy in inflammatory bowel disease: survey of adherence to published guidelines. Aliment Pharmacol Ther. 2006;23(7):1009-1018.
- NICE NG129. Crohn's disease: management. NICE. 2019 (updated 2022).
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
- Harvey-Bradshaw Index for Crohn's Disease · Inflammatory Bowel Disease
- Mayo Score for Ulcerative Colitis Activity · Inflammatory Bowel Disease
- Crohn's Disease Activity Index (CDAI) · Inflammatory Bowel Disease
- Truelove and Witts Severity Index for Ulcerative Colitis · Inflammatory Bowel Disease
- Ulcerative Colitis Endoscopic Index of Severity (UCEIS) · Inflammatory Bowel Disease
- Simplified Endoscopic Score for Crohn's Disease (SES-CD) · Inflammatory Bowel Disease
Drugs
- Natalizumab · Disease-Modifying Therapy — MS (Anti-VLA-4 Monoclonal Antibody)
- Dapsone · Anti-inflammatory / Antimicrobial
- Colchicine · Anti-inflammatory — Neutrophilic Dermatoses / Vasculitis
- Diclofenac · Non-Steroidal Anti-Inflammatory Drug (NSAID)
- Colchicine (Acute Gout) · Anti-Inflammatory (Microtubule Inhibitor)
- Diclofenac · NSAID (Non-Steroidal Anti-Inflammatory Drug)
Decision support only — verify against MDCalc, NICE, or your local guideline before clinical use.